21791. Misbranding of   Aspirsal.     U.   S.   v.   Charles   M.   Hick   (Charles   M.
Hick & Co.). Plea of guilty. Fine, $25. (F. & D. no. 27531. I.S. 
no. 37819.)
Examination of the drug preparation, Aspirsal, disclosed that it contained 
no ingredient or combination of ingredients capable of producing certain cura- 
tive and therapeutic effects claimed on the display card shipped with the 
article.
On May 6, 1932, the United States attorney for the Northern District of 
Illinois, acting upon a report by the Secretary of Agriculture, filed in the 
•district court an information against Charles M. Hick, trading as Charles M. 
Hick & Co., Chicago, Ill., alleging shipment by said defendant in violation of 
the Food and Drugs Act as amended, on or about June 15, 1931, from the 
State of Illinois into the State of Pennsylvania, of a quantity of Aspirsal that 
was misbranded. The article was labeled in part: " Hick's Pure Aspirsal 
Compounded   *   *   *   has. M. Hick & Co."
Analysis of a sample of the article by this Department showed that it con- 
sisted essentially of tablets containing acetylsalicylic acid (4.5 grains per 
tablet)  and phenolphthalein.
It was alleged in the information that the article was misbranded in that 
certain statements, designs, and devices, regarding the therapeutic and curative 
effects of the article, appearing on the display card, falsely and fraudulently 
represented that it was effective as a treatment for toothache, earache, 
rheumatism, lumbago, and sciatica.
On December 11, 1933, the defendant entered a plea of guilty to the informa- 
tion, and the court imposed a fine of $25.
M. L. WILSON, Acting Secretary of Agriculture.